ArticleBMJ (Clinical research ed.)2014
Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data.
Article in BMJ (Clinical research ed.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.
- The impact of clinical and population strategies on coronary heart disease mortality: an assessment of Rose's big idea.BMC public health · 2022Pooled it
- A Modeling Study for Hip Fracture Rates in Romania.Journal of clinical medicine · 2025Article
- EPidemiology Of Cardiogenic sHock in Scotland (EPOCHS): A multicentre, prospective observational study of the prevalence, management and outcomes of cardiogenic shock in Scotland.Journal of the Intensive Care Society · 2024Article
- Explaining declining hip fracture rates in Norway: a population-based modelling study.The Lancet regional health. Europe · 2023Article
- Is area-level socioeconomic deprivation associated with mortality due to circulatory system diseases in Poland?BMC public health · 2023Article
- Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.Circulation · 2022Article
- Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2022Article
- Serum ferritin and incident cardiometabolic diseases in Scottish adults.Cardiovascular diabetology · 2022Article
- Epidemiology of cardiovascular disease in Europe.Nature reviews. Cardiology · 2022Review
- Article
- Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: A 25-year individual patient level linkage study.The Lancet regional health. Europe · 2021Article
- Health Care Resources and 24,910 Deaths Due to Traffic Accidents: An Ecological Mortality Study in Poland.International journal of environmental research and public health · 2021Article
- Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974-2015?Heart (British Cardiac Society) · 2020Article
- Article
- Progress in reducing inequalities in cardiovascular disease mortality in Europe.Heart (British Cardiac Society) · 2020Article
- Declining cardiovascular mortality masks unpalatable inequalities.Heart (British Cardiac Society) · 2020Article
- Explaining the increment in coronary heart disease mortality in Mexico between 2000 and 2012.PloS one · 2020Article
- Article
- Perceived Neighbourhood Problems over Time and Associations with Adiposity.International journal of environmental research and public health · 2018Article
- Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark 1991-2007 using the IMPACTSEC model.PloS one · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 6 institutions in 2 countries.
Funding
Abstract
objectiveTo quantify the contributions of prevention and treatment to the trends in mortality due to coronary heart disease in Scotland.
designRetrospective analysis using IMPACTSEC, a previously validated policy model, to apportion the recent decline in coronary heart disease mortality to changes in major cardiovascular risk factors and to increases in more than 40 treatments in nine non-overlapping groups of patients.
settingScotland.
participantsAll adults aged 25 years or over, stratified by sex, age group, and fifths of Scottish Index of Multiple Deprivation.
main outcome measureDeaths prevented or postponed.
results5770 fewer deaths from coronary heart disease occurred in 2010 than would be expected if the 2000 mortality rates had persisted (8042 rather than 13,813). This reflected a 43% fall in coronary heart disease mortality rates (from 262 to 148 deaths per 100,000). Improved treatments accounted for approximately 43% (95% confidence interval 33% to 61%) of the fall in mortality, and this benefit was evenly distributed across deprivation fifths. Notable treatment contributions came from primary prevention for hypercholesterolaemia (13%), secondary prevention drugs (11%), and chronic angina treatments (7%). Risk factor improvements accounted for approximately 39% (28% to 49%) of the fall in mortality (44% in the most deprived fifth compared with only 36% in the most affluent fifth). Reductions in systolic blood pressure contributed more than one third (37%) of the decline in mortality, with no socioeconomic patterning. Smaller contributions came from falls in total cholesterol (9%), smoking (4%), and inactivity (2%). However, increases in obesity and diabetes offset some of these benefits, potentially increasing mortality by 4% and 8% respectively. Diabetes showed strong socioeconomic patterning (12% increase in the most deprived fifth compared with 5% for the most affluent fifth).
conclusionsIncreases in medical treatments accounted for almost half of the large recent decline in mortality due to coronary heart disease in Scotland. Furthermore, the Scottish National Health Service seems to have delivered these benefits equitably. However, the substantial contributions from population falls in blood pressure and other risk factors were diminished by adverse trends in obesity and diabetes. Additional population-wide interventions are urgently needed to reduce coronary heart disease mortality and inequalities in future decades.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.